Changes in Sub. S-hldr's Int (Section 138 of CA 2016) AT SYSTEMATIZATION BERHAD
Particulars of substantial Securities Holder Name FINTEC GLOBAL BERHAD Address 10th Floor, Menara Hap Seng No. 1 & 3, Jalan P. Ramlee Kuala Lumpur 50250 Wilayah Persekutuan Malaysia. Company No. 200701016619 (774628-U) Nationality/Country of incorporation Malaysia Descriptions (Class) Ordinary Shares Details of changes No Date of change No of securities Type of Transaction Nature of Interest 1 12 Mar 2020 800,000 Acquired Indirect Interest Name of registered holder Asiabio Capital Sdn. Bhd. Address of registered holder 10th Floor, Menara Hap Seng No. 1 &3, Jalan P. Ramlee 50250 Kuala Lumpur Description of "Others" Type of Transaction 2 06 May 2020 800,000 Disposed Indirect Interest Name of registered holder Asiabio Capital Sdn. Bhd. Address of registered holder 10th Floor, Menara Hap Seng No. 1 &3, Jalan P. Ramlee 50250 Kuala Lumpur Description of "Others" Type of Transaction 3 16 May 2020 421,600,000 Others Indirect Interest Name of registered holder Asiobio Capital Sdn. Bhd. Address of registered holder 10th Floor, Menara Hap Seng No. 1 &3, Jalan P. Ramlee 50250 Kuala Lumpur Description of "Others" Type of Transaction Subscription 4 19 May 2020 69,888,833 Disposed Indirect Interest Name of registered holder Asiobio Capital Sdn. Bhd. Address of registered holder 10th Floor, Menara Hap Seng No. 1 &3, Jalan P. Ramlee 50250 Kuala Lumpur Description of "Others" Type of Transaction
Circumstances by reason of which change has occurred 1) Acquisition of shares in open market via Asiabio Capital Sdn. Bhd., a wholly-owned subsidiary - 800,000 2) Disposal of shares in open market via Asiabio Capital Sdn. Bhd., a wholly-owned subsidiary - 800,000 3) Subscription of rights shares and excess rights shares via Asiabio Capital Sdn. Bhd., a wholly-owned subsidiary- 421,600,000 4) Disposal of shares in open market via Asiabio Capital Sdn. Bhd., a wholly-owned subsidiary - 69,888,833 Nature of interest Indirect Interest Direct (units) Direct (%) Indirect/deemed interest (units) 421,600,000 Indirect/deemed interest (%) 28.292 Total no of securities after change 421,600,000 Date of notice 27 May 2020 Date notice received by Listed Issuer 27 May 2020 https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3053344
Small and mid-cap stocks offer better value at the moment, says RHB May 15, 2020 KUALA LUMPUR: Small and mid-cap stocks offer better value at the moment given that their large-cap peers have staged solid rebounds off their March lows, RHB Investment Bank Bhd (RHB IB) said. Shares of small-cap companies had lagged behind in staging strong recovery rebounds from Bursa Malaysia's March 18 dip, the bank said. RHB IB chief executive officer Robert Huray said alpha hunting remained a daunting task for most investors against the backdrop of heightened uncertainties in light of Covid-19. This was given the fact that Bursa's key index FBMKLCI had rallied vigorously, narrowing its year-to-date (YTD) losses to 13 per cent. This had ultimately raised the question of further upside potential for big liquid stocks, Hurray said at the virtual launch of RHB Top 20 Malaysia Small Cap Jewels 2020 (RHB Top 20) book here today, He said the small-mid cap space had offered investors a 27 per cent gain versus a -4.4 per cent for FBMKLCI last year. The segment, though, is still off from its peak by a much wider margin, down 23 per cent YTD. "With the fate of many bigger companies tied to waning external demand, low commodity prices and dwindling capacity to spend locally, chances of finding winners in the new norm post Covid-19 will be higher for smaller and nimbler companies that can better capitalise on emerging opportunities," Huray said. RHB Top 20 features 20 names for investors to consider during this challenging period in the wake of the Covid-19 pandemic. Hurray said its top 20 firms had collectively outperformed the FBM KLCI and the FBM Small Cap Index with a holding period return of 20 per cent since the book's launch last May. RHB IB head of regional equity research Alexander Chia said it had begun to see value in the market in a longer-term perspective, despite the elevated risk environment as the result of Covid-19. "We believe the launch of the book is well-timed as we are seeing strong demand for alpha rich small-mid caps stocks that are resilient and can survive the on-going turmoil," Chia added. In this year's book, the largest stock by market cap, at RM1.7 billion, is Mi Technovation, while the smallest is Advancecon Holdings Bhd at RM122 million. Of the top 20 "jewels", 65 per cent have a market cap of less than RM500 million. The trailing median price-to-earnings-ratio and return on equity of this year's pick are 12.6 times and 11.7 per cent respectively. The RHB Top 20 forms part of the larger RHB Regional Small Cap Compendium that annually lists stock investment ideas from RHB IB's research teams in Malaysia, Indonesia, Singapore and Thailand. RHB IB said companies in this year's book have market capitalisation of below RM2 billion, from 10 different industry segments with the biggest representation coming from the technology and industrial products and services sectors. The screening process took into consideration the companies' spread and size, managements' credibility, industry fundamentals, earnings growth potential, industry track record and its level of corporate governance.
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS FINTEC GLOBAL BERHAD ["FINTEC" or "the Company"] - SUBSCRIPTION OF RIGHTS AND EXCESS SHARES OF AT SYSTEMATIZATION BERHAD PURSUANT TO RULE 9.19(26) AND RULE 10.06 OF THE ACE MARKET LISTING REQUIREMENTS FINTEC GLOBAL BERHAD
Type Announcement Subject TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS Description FINTEC GLOBAL BERHAD ["FINTEC" or "the Company"] - SUBSCRIPTION OF RIGHTS AND EXCESS SHARES OF AT SYSTEMATIZATION BERHAD PURSUANT TO RULE 9.19(26) AND RULE 10.06 OF THE ACE MARKET LISTING REQUIREMENTS We refer to the announcement dated 27 May 2020.
On behalf of the Board of Directors of the Company, we wish to make further amendment to the announcement dated 27 May 2020 as follows:-
a) Item 1 – Introduction:
The Board of Directors of FINTEC wishes to announce that its wholly-owned subsidiary, Asiabio Capital Sdn. Bhd. (“ABC”), that is principally involved in the trading of marketable securities has on 16 May 2020 18 May 2020 acquired 421,600,000 new ordinary shares of AT Systematization Berhad (“ATS”) via the subscription of the rights and excess shares of ATS at an issue price of RM0.035 each (“Shares”), representing 28.29% equity interest of the enlarged share capital in ATS, for a total cash consideration of RM14,756,000.00 (“Consideration”). Pursuant to the acquisition, ABC will also be issued 316,200,000 free Warrants C of ATS (hereinafter referred to as the “Subscription”).
Please refer to the announcement dated 27 May 2020 for more details.
Furthermore, we wish to announce that the Subscription has been completed on 22 May 2020 following the listing and quotation of the Shares and Warrants C as per the timeframe detailed hereunder:-.
1) 421,600,000 new Shares of ATS and 316,200,000 Warrants C were allotted to ABC on 18 May 2020.
2) 421,600,000 new Shares of ATS and 316,200,000 Warrants C were credited to ABC on 21 May 2020.
3) 421,600,000 new Shares of ATS and 316,200,000 Warrants C were listed on 22 May 2020.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Daily8
3,858 posts
Posted by Daily8 > 2020-05-27 20:02 | Report Abuse
NO UP EVERYBODY CURSE AD SWEAR HAHA